be_ixf;ym_202004 d_01; ct_50

Select Page

Nick Tate

Nick TateNick Tate Senior Editorial Manager for Bold Profits Daily, Profits Unlimited and Paul Mampilly’s other premium trading publications.

Nick Tate is the senior editorial manager for Bold Profits Daily, Profits Unlimited and Paul Mampilly’s other premium trading publications.

As a best-selling author, seasoned journalist and TV commentator specializing in health care, finance and biotech, Nick is all about big ideas and innovations — always keeping his followers informed on the next big thing.

His work has appeared in The Miami Herald, The Atlanta Journal-Constitution, South Florida Business Journal, Newsmax Magazine, South Florida Sun Sentinel, Boston Herald, and on Newsmax TV and the Al Jazeera network.

His top-selling book, the ObamaCare Survival Guide, was on the Publishers Weekly and The New York Times best-sellers lists for 22 weeks — reaching No. 1 on The Times list for paperback advice books.

Tate also co-authored DaVinci’s Baby Boomer Survival Guide: Live, Prosper, and Thrive in Your Retirement. And he published two other books — the Encyclopedia of Natural Healing and The Sick Building Syndrome — following a year-long journalism fellowship at the Harvard School of Public Health.

Tate’s three-decades-long commitment to keeping the public well-informed is why Banyan Hill Publishing recruited him in 2018 to join Paul Mampilly’s team. You can now read Nick’s weekly analysis in Bold Profits Daily as he guides over 130,000 readers on the best ways to grow their wealth.

Nick Tate's Articles

telemedicine is the future 2 Buys for the Coronavirus-Fueled Telemedicine Trend - Telemedicine use is through the roof with the COVID-19 crisis — proving it’s both a promising health care alternative and profitable investment.
matches ignite like Coronavirus sector Coronavirus Set to Ignite This Sleeper Sector to New Highs - Panic accelerates change. And the “coronavirus effect” has sent stocks on a roller-coaster ride, clearing the way for a new-world market. The biggest winners will be in this sleeper sector.
No. 1 Strategy for the Coronavirus Stock Market Rebound - Story Highlights: Why you shouldn’t panic over the market dips this week. A new coronavirus breakthrough shines a spotlight on a precision medicine ETF that’s on a tear. Paul Mampilly’s secret investing weapon to use during the “coronavirus effect” on the stock market. The coronavirus vaccine is here! We predicted it a few weeks back, […]
Cancer App that could change everything Invest in the New Cancer App Technology for 29% Every Year - A new phone app uses artificial intelligence to identify a rare form of cancer. It’s just the latest example of how AI is fueling the a HUGE precision medicine boom.
Smart Diabetes Patch Smart Diabetes Patch Breakthrough for Huge Biotech Gains - A new “smart” patch delivers personalized, precise doses of medication to treat diabetes. This precision medicine advance is the latest to showcase the coming 985% boom in this America 2.0 mega trend.
3 Steps for Investing in the Coronavirus “Cure” by March - Coronavirus “cure” by March? Fast-track your portfolio by buying into precision medicine’s 985% boom now.
coronavirus Coronavirus “Cure” Reveals 300%-Plus Gains Opportunity - The coronavirus “cure” is just one of several innovations in medicine that is remaking the U.S. health care system as we know it.
Top Stocks for America 2.0’s Telehealth Revolution - The next generation of telehealth tools is here — artificial intelligence, better remote sensors and genetics — remaking U.S. health care with a new, personal, “virtual” spin.
3D printing and precision medicine 3D Printing + Precision Medicine = Massive 2020 Profits - Precision medicine just took a massive leap forward. This mega medical trend in personalized health care offers investors huge profit potential.
dinosaurs Dinosaur Stocks: No. 1 Biggest Mistake You Can Make in 2020 - It’s the most important factor in whether a stock is a superstar or a black hole for your money: innovation.



I am up $20,070 in closed positions from Feb. 18 through March 7.

- Bob Rowe

I started your system in December … I am ahead $29,000 … I put total faith in you and your system and it has worked for me very nicely. Thanks again I sure like your humble approach about this whole thing

- Dale Leiffer

I have made a little over $4,000 while being cautious.

- Chuck Goss